- Report
- October 2024
- 198 Pages
Global
From €3234EUR$3,545USD£2,764GBP
€3593EUR$3,939USD£3,071GBP
- Report
- February 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,501GBP
- Report
- May 2024
- 185 Pages
Global
From €4105EUR$4,500USD£3,509GBP
- Report
- May 2023
- 206 Pages
Global
From €4516EUR$4,950USD£3,860GBP
- Report
- May 2023
- 102 Pages
Global
From €3500EUR$4,110USD£3,096GBP
- Book
- January 2022
- 720 Pages
- Book
- April 2021
- 288 Pages
- Book
- February 2021
- 544 Pages
- Book
- September 2024
- 352 Pages
- Book
- March 2022
- 336 Pages
- Book
- February 2022
- 1024 Pages
Global
- Book
- December 2021
- 448 Pages
- Book
- December 2021
- 544 Pages
- Book
- February 2018
- 880 Pages
- Book
- February 2017
- 432 Pages
- Book
- March 2014
- 312 Pages
- Book
- June 2020
- 200 Pages
The Cytoskeleton market is a subset of the biotechnology industry that focuses on the study of the structure and function of the cytoskeleton. This includes the microtubules, microfilaments, and intermediate filaments that make up the cytoskeleton. The cytoskeleton is responsible for the maintenance of cell shape, movement of organelles, and cell division. It is also involved in cell signaling, cell adhesion, and intracellular transport.
The cytoskeleton market is driven by the need for better understanding of the structure and function of the cytoskeleton, as well as the development of new treatments for diseases related to the cytoskeleton. Companies in this market are focused on developing new technologies and products to study the cytoskeleton, as well as developing new treatments for diseases related to the cytoskeleton.
Some companies in the Cytoskeleton market include Thermo Fisher Scientific, Merck KGaA, Sigma-Aldrich, Abcam, Cell Signaling Technology, Bio-Rad Laboratories, and BD Biosciences. Show Less Read more
